FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

31016311000001100: Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 09-Dec 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
95783001000001119 Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
95783101000001118 Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) Is a Product containing precisely tolvaptan 15 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) Has active ingredient Tolvaptan false Inferred relationship Existential restriction modifier
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) Has specific active ingredient Tolvaptan true Inferred relationship Existential restriction modifier
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) Has excipient Lactose false Inferred relationship Existential restriction modifier
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) Is a Jinarc true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) 7 tablet Has AMP True Jinarc 15mg tablets (Otsuka Pharmaceuticals (U.K.) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start